Pharmaceutical

CJ-15314 by HK inno.N for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval

CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Atopic Dermatitis (Atopic Eczema).

Jul 7, 2023 - 20:00
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Atopic Dermatitis (Atopic Eczema).
Read the original article

Tags:

Previous Article

ORIN-1001 by Shanghai Fosun Pharmaceutical (Group) for Kidney Cancer (Renal Cell...

Next Article

AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Congress must reauthorize the National Advisory Committee for Seniors and Disasters

Opinion: Congress must reauthorize the National Advisor...

Nov 13, 2023

Takeda wins EU approval for paediatric use of Takhzyro in HAE

Takeda wins EU approval for paediatric use of Takhzyro ...

Nov 20, 2023

Cardurion closes $260m in Series B to develop cardiovascular pipeline

Cardurion closes $260m in Series B to develop cardiovas...

Jul 18, 2024